Entity Details

Primary name HEM0_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionP22557
EntryNameHEM0_HUMAN
FullName5-aminolevulinate synthase, erythroid-specific, mitochondrial
TaxID9606
Evidenceevidence at protein level
Length587
SequenceStatuscomplete
DateCreated1991-08-01
DateModified2021-06-02

Ontological Relatives

GenesALAS2

GO terms

Show/Hide Table
GOName
GO:0001666 response to hypoxia
GO:0003870 5-aminolevulinate synthase activity
GO:0005739 mitochondrion
GO:0005743 mitochondrial inner membrane
GO:0005759 mitochondrial matrix
GO:0006782 protoporphyrinogen IX biosynthetic process
GO:0006783 heme biosynthetic process
GO:0006879 cellular iron ion homeostasis
GO:0030170 pyridoxal phosphate binding
GO:0030218 erythrocyte differentiation
GO:0032364 oxygen homeostasis
GO:0042541 hemoglobin biosynthetic process
GO:0048821 erythrocyte development

Subcellular Location

Show/Hide Table
Subcellular Location
Mitochondrion matrix

Domains

Show/Hide Table
DomainNameCategoryType
IPR001917 Aminotransferase, class-II, pyridoxal-phosphate binding siteSiteBinding site
IPR004839 Aminotransferase, class I/classIIDomainDomain
IPR010961 Tetrapyrrole biosynthesis, 5-aminolevulinic acid synthaseDomainDomain
IPR015118 5-aminolevulinate synthase presequenceDomainDomain
IPR015421 Pyridoxal phosphate-dependent transferase, major domainFamilyHomologous superfamily
IPR015422 Pyridoxal phosphate-dependent transferase, small domainFamilyHomologous superfamily
IPR015424 Pyridoxal phosphate-dependent transferaseFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
300751 OMIMAnemia, sideroblastic, 1 (SIDBA1)A form of sideroblastic anemia that shows a variable hematologic response to pharmacologic doses of pyridoxine. Sideroblastic anemia is characterized by anemia of varying severity, hypochromic peripheral erythrocytes, systemic iron overload secondary to chronic ineffective erythropoiesis, and the presence of bone marrow ringed sideroblasts. Sideroblasts are characterized by iron-loaded mitochondria clustered around the nucleus. The disease is caused by variants affecting the gene represented in this entry.
300752 OMIMErythropoietic protoporphyria, X-linked dominant (XLDPT)A form of porphyria. Porphyrias are inherited defects in the biosynthesis of heme, resulting in the accumulation and increased excretion of porphyrins or porphyrin precursors. They are classified as erythropoietic or hepatic, depending on whether the enzyme deficiency occurs in red blood cells or in the liver. XLDPT is characterized biochemically by a high proportion of zinc-protoporphyrin in erythrocytes, in which a mismatch between protoporphyrin production and the heme requirement of differentiating erythroid cells leads to overproduction of protoporphyrin in amounts sufficient to cause photosensitivity and liver disease. The disease is caused by variants affecting the gene represented in this entry. Gain of function mutations in ALS2 are responsible for XLDPT, but they can also be a possible aggravating factor in congenital erythropoietic porphyria and other erythropoietic disorders caused by mutations in other genes (PubMed:21309041).

Drugs

Show/Hide Table
DrugNameSourceType
DB00114 Pyridoxal phosphateDrugbanksmall molecule
DB00145 GlycineDrugbanksmall molecule

Interactions

4 interactions